BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27697286)

  • 1. The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
    Torkaman M; Ghollasi M; Mohammadnia-Afrouzi M; Salimi A; Amari A
    Cell Immunol; 2017 Jan; 311():1-12. PubMed ID: 27697286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
    Donders R; Vanheusden M; Bogie JF; Ravanidis S; Thewissen K; Stinissen P; Gyselaers W; Hendriks JJ; Hellings N
    Cell Transplant; 2015; 24(10):2077-98. PubMed ID: 25310756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.
    Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J
    Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Wharton's Jelly-Derived Mesenchymal Stromal Cells Primed by Tumor Necrosis Factor-α and Interferon-γ Modulate the Innate and Adaptive Immune Cells of Type 1 Diabetic Patients.
    Mrahleh MA; Matar S; Jafar H; Wehaibi S; Aslam N; Awidi A
    Front Immunol; 2021; 12():732549. PubMed ID: 34650558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Generation of IL-35-expressing Human Wharton's Jelly-derived Mesenchymal Stem Cells Using Lentiviral Vector.
    Amari A; Ebtekar M; Moazzeni SM; Soleimani M; Mohammadi Amirabad L; Tahoori MT; Massumi M
    Iran J Allergy Asthma Immunol; 2015 Aug; 14(4):416-26. PubMed ID: 26547710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.
    Tsai PJ; Wang HS; Lin GJ; Chou SC; Chu TH; Chuan WT; Lu YJ; Weng ZC; Su CH; Hsieh PS; Sytwu HK; Lin CH; Chen TH; Shyu JF
    Cell Transplant; 2015; 24(8):1555-70. PubMed ID: 25198179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
    Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
    Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of immunomodulatory properties of human Wharton's Jelly-derived mesenchymal stem cells after lentiviral transduction.
    Amari A; Ebtekar M; Moazzeni SM; Soleimani M; Amirabad LM; Tahoori MT; Massumi M
    Cell Immunol; 2015 Feb; 293(2):59-66. PubMed ID: 25569483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis.
    Yousefi F; Ebtekar M; Soudi S; Soleimani M; Hashemi SM
    Immunol Lett; 2016 Apr; 172():94-105. PubMed ID: 26930038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M
    Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.
    Lee HS; Kim KS; Lim HS; Choi M; Kim HK; Ahn HY; Shin JC; Joe YA
    J Cell Biochem; 2015 Feb; 116(2):310-9. PubMed ID: 25185536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
    Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
    Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
    Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
    Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model.
    Hu J; Wang Y; Wang F; Wang L; Yu X; Sun R; Wang Z; Wang L; Gao H; Fu Z; Zhao W; Yan S
    Endocrine; 2015 Feb; 48(1):124-34. PubMed ID: 24590294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
    Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
    Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
    Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
    Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.